European Commission published today calls for proposals for the 2016-2017 period. The calls can be already found in Participant Portal and you can already consult the different opening dates. There are a few changes versus the previous calls.

For example for the SME Instrument the cut-off dates have changed as well as some topics.

New cut-off dates:
2016
Phase 1
09 Nov 2017 17:00
2017
Phase 1
15 Feb 2017 17:00

03 May 2017 17:00

06 Sep 2017 17:00

08 Nov 2017 17:00

2017
Phase 2
18 Jan 2017 17:00

06 Apr 2017 17:00

01 Jun 2017 17:00

18 Oct 2017 17:00

  

Expected Impact SME instrument 1:

  • Enhancing profitability and growth performance of SMEs by combining and transferring new and existing knowledge into innovative, disruptive and competitive solutions seizing European and global business opportunities.
  • Market uptake and distribution of innovations[[In the case of SMEInst-05-2016-2017, the development of innovative solutions should lead to value creation through the increased use of cell-based products/processes, biomarkers and/or diagnostic medical devices in industrial or clinical settings, and should contribute to technical and regulatory progress in these domains.]] tackling the specific challenges in a sustainable way.
  • Increase of private investment in innovation, notably leverage of private co-investor and/or follow-up investments.
  • The expected impacts should be clearly described in qualitative and quantitative terms (e.g. on turnover, employment, market seize, IP management, sales, return on investment and profit).

Budget Information SME instrument:

The budget available for phase 1 and phase 2 will be divided equally between each cut-off date.

Up to 10 % of the annual budget will be used for phase 1 funding; 87% of the annual budget for phase 2 funding; at least 1% will be used for phase 3 related actions. In addition, 1% of the budget will be used to support coaching and mentoring activities supporting phase 1 and 2. Other than that, up to 1% of the annual budget will be used for evaluation.

   
© H. W. Berghoff & ALLROUNDER